Clinical Pharmacokinetics, 57 (12), 15291538
BPC-157 begin 200-300mcg daily potentially increasing to 500mcg if well-tolerated
A personalized genetic assessment may reveal whether you have genetic predispositions that favor GLP-1 monotherapy, alternative mechanisms, or heightened sensitivity to sympathomimetic effects
If you have diabetes, check your blood sugar levels regularly to help mitigate complications from low blood sugar
Tirzepatide also acts on GIP receptors, which makes it mechanistically different
It is a text-based questionnaire that collects your medical history, current medications, height, weight, and health goals